http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Pre-Open Movers 1/12: (ARDM) (WATT) (EXAS) (FCEL) (FB) (TMHC) (More..)
-
Exact Sciences (EXAS) Reports Prelim. Q4 & FY17 Revenues Above Consensus
-
Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017
-
Exact Sciences to participate in J.P. Morgan Healthcare Conference
-
Exact Sciences to Expand Laboratory and Corporate Facilities in Madison
-
Exact Sciences to participate in two investor conferences during November
-
Cologuard® revenue increased 158 percent to $73 million during third quarter
-
Exact Sciences reschedules third-quarter 2017 earnings call to Oct. 30
-
Exact Sciences schedules third-quarter 2017 earnings call
-
Exact Sciences to participate in Baird Global Healthcare Conference
-
Exact Sciences to participate in Canaccord Genuity Growth Conference
-
Cologuard® revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests
-
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees
-
Exact Sciences to host second-quarter 2017 results, annual meeting webcasts and calls
-
Jerry Kelly and Exact Sciences Team Up to Promote Colon Cancer Screening
-
Exact Sciences (EXAS) Prices 7M Share Offering at $35
-
Exact Sciences Announces Pricing of Public Offering of Common Stock
-
Exact Sciences (EXAS) to Offer 7M Shares
-
Exact Sciences Announces Agreement to Sell 7,000,000 Common Shares
-
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees
-
Cologuard growth accelerates to $48.4 million in revenue during first quarter; volume grows 150 percent year over year to 100,000 completed tests
-
Exact Sciences (EXAS) Announces CMS includes Cologuard in Updated Medicare Advantage Star Ratings
-
CMS includes Cologuard in updated Medicare Advantage Star Ratings
-
Exact Sciences to host first-quarter 2017 results webcast and call
-
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees
-
Exact Sciences (EXAS), Mayo Clinic Study Shows Promise for Development of New Blood-based Lung Cancer Test
-
Exact Sciences and Mayo Clinic study shows promise of new blood-based lung cancer test
-
Fight Colorectal Cancer and Exact Sciences Corp. (Nasdaq: EXAS) to Ring The Nasdaq Stock Market Closing Bell
-
Exact Sciences generated $99.4 million in revenues during 2016, a 152-percent increase
-
Exact Sciences (EXAS) Announces CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings
-
CMS Proposes Inclusion of Cologuard in Medicare Advantage Star Ratings
-
Exact Sciences to host fourth-quarter, full-year 2016 results webcast and call
-
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees
-
Exact Sciences (EXAS) Sees Q4 Revs of $34.9-$35.4M, Vs. Consensus of $30.15M
-
Exact Sciences to report $99 million in revenues, 150 percent growth for 2016
-
Exact Sciences (EXAS) Reports Positive Review of Cologuard from Blue Cross Blue Shield Association
-
Cologuard Earns Positive Review from Blue Cross Blue Shield Association
-
Exact Sciences (EXAS) Announces Humana Agrees to Cover Cologuard
-
Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option
-
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees
-
Exact Sciences (EXAS) Names Jeff Elliott as CFO; John Bakewell to Retire
-
Exact Sciences Appoints Jeff Elliott Chief Financial Officer
-
Exact Sciences' Cologuard Wins Prestigious Prix Galien Award for Best Medical Technology Product
-
Exact Sciences Completes 68,000 Cologuard Tests During the Third Quarter
-
Cologuard® Covered for TRICARE Beneficiaries
-
Exact Sciences (EXAS) Confirms Inclusion of Cologuard in HEDIS Quality Measures
-
Exact Sciences Announces Inclusion of Cologuard® in HEDIS Quality Measures
-
Exact Sciences to host third-quarter 2016 results webcast and call
-
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees
-
Exact Sciences (EXAS) Announces Updated CMS Evidence of Coverage for Cologuard

